Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

BUY
$209.01 - $232.56 $222,804 - $247,908
1,066 Added 0.9%
119,309 $26.1 Million
Q4 2023

Jan 16, 2024

SELL
$197.69 - $227.29 $3.61 Million - $4.15 Million
-18,237 Reduced 13.36%
118,243 $26.9 Million
Q3 2023

Oct 24, 2023

BUY
$201.05 - $221.7 $4.87 Million - $5.37 Million
24,239 Added 21.6%
136,480 $27.4 Million
Q2 2023

Jul 25, 2023

BUY
$211.93 - $241.33 $4.15 Million - $4.73 Million
19,602 Added 21.16%
112,241 $27.1 Million
Q1 2023

Apr 14, 2023

BUY
$213.32 - $257.83 $316,780 - $382,877
1,485 Added 1.63%
92,639 $21.3 Million
Q4 2022

Feb 08, 2023

SELL
$203.72 - $248.97 $38,706 - $47,304
-190 Reduced 0.21%
91,154 $21.5 Million
Q3 2022

Oct 25, 2022

BUY
$204.81 - $262.19 $2.62 Million - $3.35 Million
12,783 Added 16.27%
91,344 $18.7 Million
Q2 2022

Aug 12, 2022

SELL
$213.86 - $277.87 $902,916 - $1.17 Million
-4,222 Reduced 5.1%
78,561 $18.4 Million
Q1 2022

May 11, 2022

BUY
$259.82 - $298.18 $3.67 Million - $4.22 Million
14,140 Added 20.6%
82,783 $21.8 Million
Q4 2021

Feb 08, 2022

BUY
$271.6 - $314.21 $548,632 - $634,704
2,020 Added 3.03%
68,643 $21.6 Million
Q3 2021

Nov 02, 2021

BUY
$274.82 - $308.34 $2.36 Million - $2.65 Million
8,593 Added 14.81%
66,623 $18.8 Million
Q2 2021

Aug 11, 2021

BUY
$251.87 - $278.14 $470,745 - $519,843
1,869 Added 3.33%
58,030 $16 Million
Q1 2021

May 14, 2021

BUY
$204.88 - $255.03 $784,075 - $975,999
3,827 Added 7.31%
56,161 $14.3 Million
Q4 2020

Feb 12, 2021

SELL
$186.91 - $214.42 $3.44 Million - $3.94 Million
-18,398 Reduced 26.01%
52,334 $10.7 Million
Q3 2020

Nov 04, 2020

SELL
$167.03 - $201.3 $5.23 Million - $6.31 Million
-31,341 Reduced 30.7%
70,732 $13.3 Million
Q2 2020

Jul 28, 2020

SELL
$113.31 - $182.44 $391,032 - $629,600
-3,451 Reduced 3.27%
102,073 $17 Million
Q1 2020

Apr 21, 2020

SELL
$104.32 - $195.28 $693,415 - $1.3 Million
-6,647 Reduced 5.93%
105,524 $13.3 Million
Q4 2019

Feb 12, 2020

SELL
$163.48 - $173.61 $344,942 - $366,317
-2,110 Reduced 1.85%
112,171 $19 Million
Q3 2019

Nov 07, 2019

BUY
$159.77 - $178.1 $302,284 - $336,965
1,892 Added 1.68%
114,281 $19.2 Million
Q2 2019

Aug 06, 2019

SELL
$144.16 - $172.9 $2.51 Million - $3.01 Million
-17,380 Reduced 13.39%
112,389 $19.4 Million
Q1 2019

May 06, 2019

SELL
$123.7 - $156.3 $500,119 - $631,920
-4,043 Reduced 3.02%
129,769 $19.9 Million
Q4 2018

Feb 11, 2019

SELL
$120.82 - $174.09 $8.06 Million - $11.6 Million
-66,723 Reduced 33.27%
133,812 $16.9 Million
Q3 2018

Nov 14, 2018

SELL
$167.67 - $188.27 $4.68 Million - $5.25 Million
-27,884 Reduced 12.21%
200,535 $34.8 Million
Q2 2018

Aug 14, 2018

BUY
$160.33 - $189.41 $3.32 Million - $3.92 Million
20,717 Added 9.97%
228,419 $41 Million
Q1 2018

May 14, 2018

BUY
$161.53 - $178.11 $2.98 Million - $3.29 Million
18,473 Added 9.76%
207,702 $33.6 Million
Q4 2017

Feb 14, 2018

BUY
$147.99 - $163.95 $6.34 Million - $7.02 Million
42,847 Added 29.27%
189,229 $30.2 Million
Q3 2017

Nov 13, 2017

BUY
$149.47 - $160.56 $2.03 Million - $2.18 Million
13,571 Added 10.22%
146,382 $22.1 Million
Q2 2017

Aug 14, 2017

BUY
N/A
132,811
132,811 $20.5 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.